Press "Enter" to skip to content

Indian pharma majors deny allegations of price fixing in US

The company said its US subsidiary is specifically named as a defendant with respect to five generic drugs (Ciprofloxacin HCL tablets, Glimepiride tablets, Oxaprozin tablets, Paricalcitol and Tizanidine), for an alleged "overarching conspiracy".

Original source:

Also Read:   Delay in notification of e-pharmacy draft rules causing concern in the sector: Ficci